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Lysobactin (katanosin B) is a macrocyclic depsipep-
tide, displaying high antibacterial activity against
human pathogens. In this work, we have identified
and characterized the entire biosynthetic gene
cluster responsible for lysobactin assembly.
Sequential analysis of the Lysobacter sp. ATCC
53042 genome revealed the lysobactin gene cluster
to encode two multimodular nonribosomal peptide
synthetases. As the number of modules found within
the synthetases LybA and LybB directly correlates
with the primary sequence of lysobactin, a linear
logic of lysobactin biosynthesis is proposed. Investi-
gation of adenylation domain specificities in vitro
confirmed the direct association between the syn-
thetases and lysobactin biosynthesis. Furthermore,
an unusual tandem thioesterase architecture of the
LybB termination module was identified. Biochem-
ical characterization of the individual thioesterases
in vitro provides evidence that solely penultimate
thioesterase domain mediates the cyclization and
simultaneous release of lysobactin.
INTRODUCTION
Antibiotic resistance caused by misuse or overprescription of
antibiotics has become a serious threat to public health.
The rise of multiresistant pathogens like methicillin-resistant
Staphylococcus aureus (MRSA) and vancomycin-resistant
enterococci (VRE) emphasizes the urgent requirement for the
development of new antibiotics to ensure therapeutic efficiency
against multiresistant pathogens in the future. Efforts to address
the prevalence of pathogens include the discovery of new
bactericidal compounds or the modification of known antibiotics
by means of chemical, chemoenzymatic or mutasynthetic
approaches (Debono et al., 1988; Mahlert et al., 2005; Nguyen
et al., 2010; Weist et al., 2004).
One of the recently discovered potential antibiotics of the
future is lysobactin, a depsipeptide produced by Lysobacter
sp. ATCC 53042, which was first isolated at the Squibb Institute
of Medical Research (Figure 1) (Bonner et al., 1988; O’Sullivan
et al., 1988). Lysobactin displays a very strong activity against
Gram-positive bacteria such as MRSA and VRE, with minimumChemistry & Biology 18,inhibitory concentrations (MIC) of 0.39 and 0.78 mg/mL respec-
tively, which are obviously lower (2- to 50-fold for different
strains) than the MIC of vancomycin (Maki et al., 2001). In vitro
studies showed that lysobactin inhibits the formation of lipid
intermediates during bacterial cell wall biosynthesis, which is
not inhibited by vancomycin. As this observation indicates that
lysobactin differs in the mode of action from vancomycin it could
potentially evade resistance mechanisms developed by vanco-
mycin resistant strains (Maki et al., 2001). Lysobactin is therefore
considered a high potential agent for the treatment of bacterial
infections caused by resistant pathogens (Guzman-Martinez
et al., 2007).
To obtain access to lysobactin, various synthetic pathways
have been elaborated offering the opportunity to generate lyso-
bactin derivatives with an altered or improved pharmaceutical
spectrum (Campagne, 2007; Guzman-Martinez et al., 2007;
von Nussbaum et al., 2007). However, the discovery of the lyso-
bactin biosynthetic gene cluster could enable combinatorial
biosynthesis of lysobactin analogs via the targeted reprogram-
ming of genes encoding the enzymatic machinery involved in
lysobactin assembly in vivo.
Lysobactin itself consists of 11 amino acids and features
a 9-membered macrolactone ring with two N-terminal exocyclic
residues (von Nussbaum et al., 2007). The peptide core is
composed of a set of nonproteinogenic amino acids including
two D-configured amino acids (D-Leu1 and D-Arg6), three
b-hydroxylated amino acids (hyPhe3, hyLeu4 and hyAsn10), and
allo-Thr8 (Figure 1). The macrolactone ring is constituted of an
ester bond between the b-hydroxy group of hyPhe3 and the
carboxyl-group of Ser11. As the macrocyclic structure and the
nonproteinogenic residues are common features of nonriboso-
mally assembled peptides (NRPs), it was suggested that lyso-
bactin is synthesized by nonribosomal peptide synthetases
(NRPSs). NRPSs are modularly-organized megaenzymes, which
can be subdivided into individual modules with each module
being responsible for the activation, covalent tethering and
incorporation of a building block into the growing oligopeptide
chain (Marahiel and Essen, 2009; Schwarzer et al., 2003; Walsh
and Fischbach, 2010). These modules can be furthermore
dissected into individual, catalytically-active domains. The
adenylation (A) domains govern the recognition and activation
of the cognate substrate as an aminoacyl-adenylate, which is
subsequently transferred and covalently tethered onto the
phosphopantetheinylated peptidyl-carrier-protein (PCP). Con-
densation of the immobilized substrates and peptidyl-inter-
mediates is mediated by condensation (C) domains, leading to
the translocalization of the elongated peptidyl chain toward the655–664, May 27, 2011 ª2011 Elsevier Ltd All rights reserved 655
Figure 1. The Chemical Structure and Primary Sequence of the Anti-
biotic Lysobactin
Lysobactin itself consists of 11 amino acids, featuring a macrolactone ring
constituted of 9 amino acids and an ester bond between hyPhe3 and Ser11.
Hydroxylated amino acids are accentuated in green, whereas inverted ster-
eocenters are given in red. See also Figure S1.
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bled enzyme-bound oligopeptide via hydrolysis ormacrocycliza-
tion is generally governed by thioesterase (TE) domains, located
C-terminally in the assembly line (Kopp and Marahiel, 2007a;
Trauger et al., 2000).
In 1996, the involvement of a nonribosomal peptide synthe-
tase in lysobactin biosynthesis was confirmed via hybridization
of genomic libraries of Lysobacter sp. ATCC53042 with oligonu-
cleotides derived from core-motifs of ACV synthetases and the
gramicidin S synthetase (Bacillus brevis) (Bernhard et al.,
1996). Marker-exchange mutagenesis, employing a 4.6-kbp
NRPS-encoding DNA-fragment, gave rise to lysobactin nonpro-
ducing mutants, proving the identified DNA fragment to encode
a region of the lysobactin synthetase. Bioinformatic analysis
of the fragment revealed it to code for a truncated tetradomain
NRPS with a C-A-PCP-C organization. Comparison of the
active-site residues, determining the adenylation domain
(A-domain) specificities with known A-domains, suggested this
A-domain to activate asparagine. As an asparagine residue is
found within lysobactin at position 10 it was assumed that the
module identified was the penultimate module. Although
lysobactin has first been described in 1996 (Bernhard et al.,
1996), the entire sequence of the corresponding gene cluster
remains elusive for more than a decade.
In this study, we report the identification and sequential
analysis of the gene cluster responsible for lysobactin biosyn-
thesis in Lysobacter sp. ATCC 53042. The synthetases LybA
and LybB were confirmed to be involved in the assembly of
the antibiotic via biochemical characterization of several adeny-
lation domains in vitro. Annotation and bioinformatic analysis of
the modular organization of LybB revealed the synthetase to
harbor an unusual tandem TE architecture within the termination
module. The individual TE1/TE2 domains were heterologously656 Chemistry & Biology 18, 655–664, May 27, 2011 ª2011 Elsevierproduced and biochemically characterized in vitro, using thio-
ester-activated peptidyl substrates. It was shown that TE1 was
exclusively responsible for the regio- and stereoselectivemacro-
cyclization of the undecapeptidyl substrate, whereas TE2 solely
catalyzed hydrolysis of the peptidyl-thioester. In total, the results
presented herein provide first information on themolecular archi-
tecture of the lysobactin synthetase and give insights into the
catalytic function of a tandem thioesterase architecture. It also
provides the opportunity for the generation of lysobactin analogs
via combinatorial biosynthesis in vivo or via chemoenzymatic
synthesis in vitro.
RESULTS AND DISCUSSION
Identification and Sequential Analysis of the Lysobactin
Biosynthetic Gene Cluster
To identify the gene cluster responsible for lysobactin assembly,
the genomic DNA of Lysobacter sp. ATCC 53042 was isolated
and sequenced using pyrosequencing methods on a GS FLX
instrument (see Supplemental Experimental Procedures avail-
able online). Lysobactin production by the strain employed
was confirmed before sequencing via LC-MS analysis of culture
extractions to ensure a functional biosynthetic assembly line.
Lysobactin showed a retention time of tR = 19.5 (m/z = 1276.8
[M + H]+ observed, m/z = 1276.7 [M + H]+ calculated) under
the conditions applied (Figure S1). Genomic sequencing was
carried out by GATC-biotech, providing 418 contigs ranging
from 553 to 150,063 bp. One of the contigs was identified using
the reported 4.6 kbp gene fragment (Bernhard et al., 1996). This
contig, covering a region of 150,063 bp with an average GC-
content of 70.7% was further analyzed using GeneMark2.4
annotation and has been submitted to GenBank (accession
number JF412274) (Borodovsky et al., 2003). A detailed over-
view of the annotated genes, the deduced protein functions
and the similarities to homologs is found in Table S1. The
proposed lyb gene cluster encodes the two NRPSs LybA and
LybB, three proteins conferring resistance to antibiotics (ORF78,
ORF80, and ORF82) and one ABC-transporter permease/ATP-
binding component (ORF79), putatively involved in the secretion
of lysobactin (Figure 2).
The synthetase LybA displays 50% identity and 64% similarity
(E-value = 0.0) to an NRPS from Pseudomonas syringae pv.
syringae B728a, whereas LybB shows 39% identity and 59%
similarity (E-value = 0.0) to a multimodular NRPS from Herpeto-
siphon aurantiacus ATCC 23779. Bioinformatic analysis of LybA
and LybB, using the NRPS-PKS prediction software, revealed
a multimodular organization (Figure 3) (Ansari et al., 2004).
LybA comprises four modules with a total of 11 domains,
whereas LybB harbors 7 modules and 24 domains. As the
number of A-domains found within LybA and LybB directly
correlates with the primary sequence of lysobactin, a linear logic
of lysobactin assembly is suggested. The 4.6-kbp gene fragment
was found to code for the tetradomain-region (C-A-PCP)10-C11,
as assumed previously (Bernhard et al., 1996). Analysis of
A-domain specificities was carried out with NRPSpredictor and
compared the extracted active-site residues determining the
A-domain specificities with known A-domains (Table S2)
(Rausch et al., 2005; Stachelhaus et al., 1999) The predicted
specificities of LybA and LybB nicely correlate with the primaryLtd All rights reserved
Figure 2. Schematic Overview of the Lysobactin Biosynthetic Gene
Cluster and the Corresponding Upstream and Downstream Regions
Functions of the proteins encoded within this region are based on BLAST-
analysis and are given in the figure. Apart from the core components for the
nonribosomal assembly of lysobactin by the synthetases LybA and LybB,
genes coding for transporters and resistance-conferring proteins are found.
See also Table S1.
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Insights into Lysobactin Biosynthesisstructure of lysobactin. In addition, the extracted active-site
residues display a high degree of sequential identity to known
active-site residue patterns with the weakest identity being
70% for LybB-A6.
LybA A3 is predicted to activate L-phenylalanine but shows
only 80% identity of the residues determining the specificity
compared to BacC A2, suggesting the activation of a structurally
analogous building block (Konz et al., 1997). This variation in the
specificity conferring motif might indicate the direct incorpora-
tion of hyPhe located at position 3 in lysobactin instead of the
activation of L-Phe followed by hydroxylation in trans. Thismodel
would require the hydroxylation of the free amino acid substrate,Figure 3. Modular Organization of the Lysobactin Synthetases LybA a
LybA consists of 4 modules and 11 domains, respectively. LybB is constituted of
found within the synthetases directly correlates with the primary sequence of l
contains two distinct thioesterase domains, responsible for release of the PCP
biochemical characterization in vitro are marked with an asterisk. See also Figur
Chemistry & Biology 18,which has already been reported for Cb-hydroxylation of L-Arg
during viomycin biosynthesis (Helmetag et al., 2009). In contrast,
the extracted active-site residues of LybA A4 are identical to
those found in the L-Leu activating A-domain of SrfA-A-A3,
involved in surfactin biosynthesis (Cosmina et al., 1993). Further-
more, the specificity conferring code of LybB-A10 exactly resem-
bles the code found in NosC-A3, responsible for the recognition
and activation of L-Asn. Based on these results it is suggested
that LybA-A4 and LybB-A10 activate the nonhydroxylated
building blocks L-Leu and L-Asn, which are tethered on the
adjacent PCPs. Subsequently, hydroxylation is carried out by
in trans-operating hydroxylases, recognizing the PCP-bound
substrates. This in trans tailoring mechanism has already been
reported for the biosynthesis of kutznerides and involves
nonheme Fe(II)/a-KG-dependent monooxygenase, mediating
the hydroxylation of the immobilized substrates (Strieker et al.,
2009). Alternatively, LybA A4 and LybB A10 could activate the
hydroxylated building blocks due to relaxed substrate specific-
ities, as observed for the SalB A-domain during the biosynthesis
of salinosporamide, which was exploited for the engineered
biosynthesis of antiprotealide and salinosporamide derivatives
(McGlinchey et al., 2008).
Examination of the synthetases revealed additional unusual
features of the biosynthetic assembly line. Interestingly, modules
1 and 6, incorporating D-Leu1 and D-Arg6 are not equipped with
an optional epimerization domain (E-domain), usually required
for the stereoinversion of the a-stereocenter. Instead, the con-
densation domains (C-domain) located in the downstream
neighboring modules (2 and 7) carry characteristic N-terminal
sequences with the additional core motif HHI/LXXXXGD. This
core motif has been found in dual C/E domains that catalyze
the epimerization of the Ca-atom of the PCP-bound amino acid
before condensation as observed during arthrofactin biosyn-
thesis (Balibar et al., 2005). These dual C/E domains in module
2 of LybA and module 7 of LybB are therefore considered to
be responsible for the Ca-epimerization of Leu1 and Arg6.nd LybB
7 modules and 24 individual domains. As the number of adenylation domains
ysobactin, its assembly follows a linear NRPS logic. The termination module
-bound intermediate via macrolactonization. Domains that were subjected to
e S2 and Table S2.
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Figure 4. Analysis of Recombinant Adenylation Domains
(A) SDS-PAGE analysis of purified recombinant adenylation domains LybA A1 (56.9 kDa), LybB A6 (60.3 kDa), and LybB A9 (58.2 kDa). Protein marker (M) was
broad range protein marker P7702 (NEB).
(B) The reaction catalyzed by NRPS A-domains in vitro. The radioactive ATP/PPi-exchange assay is based on the reversibility of aminoacyl-adenylate formation.
(C) Relative activities of the investigated A-domains toward various amino acid substrates as observed during pyrophosphate exchange assays.
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product, contains an additional domain inserted between the
C8- and the A8-domain (Figure 3). This domain was classified
as a C-domain by NRPS-PKS and the NRPS prediction blast
server (Ansari et al., 2004; Challis et al., 2000). Analysis of the
A-domain specificity in vitro demonstrated A8 to display a higher
affinity for L-Thr over allo-Thr (5-fold, data not shown). Based on
these results it is proposed that the inserted domain acts as
a side-chain epimerization domain, which inverts the stereo-
chemistry of the Cb-atom of PCP-bound L-Thr. Further studies
will be conducted to prove that LybB is an exclusive example
employing an in cis epimerization mechanism to supply an allo-
amino acid. In contrast, investigation of the biosynthetic pathway
for the antimetabolite g,g-dichloroaminobutyrate revealed an
alternative mechanism of allo-amino acid incorporation. In vitro
analysis of the lone-standing A-domain CytC1 confirmed the
enzyme topreferentially activate L-allo-Ile,which is directly incor-
porated into the natural product (Ueki et al., 2006).
The termination module of LybB harbors an unusual tandem
thioesterase domain architecture similar to that of thearthrofactin
synthetase ArfC (Roongsawang et al., 2003). Both TE domains,
LybBTE1andLybBTE2, share sequencehomology toa/bhydro-
lase fold proteins and contain a catalytic triad consisting of
Ser-His-Asp each, suggesting both TEs to be functional. In
contrast to ArfC TE2, LybB TE2 does not house an additional
conserved GXSXG sequence motif (Roongsawang et al., 2007).
The upstream flanking region of the lyb gene cluster is
defined by orfs75–77 that encode hypothetical proteins and
a RNA-directed RNA polymerase in the reverse direction. The
downstream region of the lyb gene cluster comprises the
b-lactamase-type protein ORF78, theRND-family acriflavin resis-
tance proteins ORF80 and ORF82 and the ABC transporter
permease/ATP-binding component ORF79. Acriflavin resistance
proteins represent bacterial drug efflux proteins with a broad
substrate specificity(Tseng et al., 1999). Although the participa-658 Chemistry & Biology 18, 655–664, May 27, 2011 ª2011 Elseviertion of proteins encoded upstream and downstream of lybA and
lybB remains to be confirmed we proposed the biosynthetic
gene cluster for lysobactin assembly to be composed of lybA,
lybB, and orfs78-82. The direction of transcription for lybA, lybB,
and orfs78–82 is identical (Figure 2), suggesting a coordinated
expression of the entire biosynthetic assembly line and an ATP-
dependent efflux machinery, conferring either resistance to lyso-
bactin or being involved in product secretion (Quigley et al., 1993).
Lysobactin contains three b-hydroxylated residues, namely
hyPhe3, hyLeu4, and hyAsn10. Generally, hydroxylations are
mediated by three enzyme classes: FAD-dependent mono-
oxygenases, nonheme Fe(II)-oxygenases, and heme Fe(II)-oxy-
genases. Especially nonheme Fe(II)/a-KG-dependent monooxy-
genases have been shown to be involved in the biosynthesis of
nonribosomal peptides. It was demonstrated that either free
amino acids or PCP-tethered substrates were subjected to
hydroxylation (Strieker et al., 2007, 2009). In the case of the lyb
gene cluster, no putative hydroxylases could be identified in
the genetic region surrounding both synthetases. As the genes
required for the biosynthesis of a natural product are usually
clustered, it can only be speculated that monooxygenases
encoded in the Lysobacter genome are responsible for the
generation of hyPhe3, hyLeu4, and hyAsn10, but gene cluster
cross-talk has been described for natural product biosynthesis
(Lazos et al., 2010).
Adenylation Domain Specificities Confirm LybA
and LybB as Lysobactin Synthetases
To verify that LybA and LybB are involved in the biosynthesis of
lysobactin, the A-domains from module 1 of LybA (A1) and
modules 6 and 9 of LybB (A6 and A9) were cloned into the expres-
sion vector pET28a. Heterologous production of the proteins in
Escherichia coli BL21 and Rosetta(DE3) cells, followed by purifi-
cation using Ni-NTA agarose affinity chromatography (Figure 4A)
afforded 1.44 (A1), 0.85 (A6), and 2.09 (A9) mg/L media ofLtd All rights reserved
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ATP/PPi-exchange assays. Analysis of the assays employing
LybA A1, which is predicted to activate L-Leu in vivo, showed
L-leucine and D-leucine to represent the preferred substrates.
Structurally related amino acids, such as isoleucine, valine,
and alanine, showed reduced activities relative to D-Leu (ranging
from 0.76 to 0.25; Figure 4C). Interestingly, various other amino
acids (serine, phenylalanine, and lysine) also showed reduced
activities ranging from 0.56 to 0.24 relative to D-Leu. A-domain
selectivity is considered to be the gate-keeper ensuring the
correct incorporation of building blocks into the final product.
Nevertheless, in vitro analysis of TycA A1, involved in the biosyn-
thesis of tyrocidine, showed the recombinant protein to display
an unexpected flexibility in substrate tolerance (Schaffer and
Otten, 2009). In contrast, LybB A6 exhibited a high degree of
specificity toward L-arginine and D-arginine (Figure 4C), which
is consistent with the prediction of Arg to be the cognate
substrate for LybB A6. Activities of all other tested substrates
did not exceed 0.006, relative to L-Arg. The results obtained
for LybB A9 clearly show that solely Gly is recognized by the
A-domain in vitro, which is also in full agreement with the biosyn-
thetic model. Analysis of adenylation domain activities corrobo-
rates the predicted specificities and confirms the synthetases
LybA and LybB tomediate lysobactin assembly following a linear
logic. Interestingly, both LybA A1 and LybB A6 display an almost
equal affinity for the L- and the D-configured substrate in vitro.
The correct incorporation of the L-configured moiety is sug-
gested to be the result of the low cytoplasmic abundance of
the corresponding D-isomer or to be restricted by the specificity
of downstream C-domains at their respective donor sites (Linne
and Marahiel, 2000).
Characterization of LybB Thioesterase Activities
Product release in NRPS- or PKS-systems is generally mediated
by C-terminally located thioesterase domains, responsible for
cyclization of the intermediate or hydrolytic release of the linear
carboxylate. These internal TE domains contain a characteristic
GXSXG-motif, constituting a catalytic triadwith highly conserved
Asp and His residues. The formation of this catalytic triad con-
sisting of Ser-His-Asp leads to the deprotonation of the active-
site serine and generates a highly reactive oxyanion species.
TE-mediated cyclization is initiated by the nucleophilic attack
of the serine oxyanion onto the adjacent PCP-bound peptidyl
thioester leading to the conversion of the peptidyl thioester to
an acyl-O-TE oxoester intermediate (Sieber and Marahiel,
2005). The attack of either an internal nucleophile or of an
external water molecule onto the oxoester results in the forma-
tion of a macrocyclic species or gives rise to the linear carbox-
ylate. In addition to internal thioesterases, which are incorpo-
rated in the assembly line, external stand-alone thioesterases,
also referred to as TEIIs, are associated with the biosynthesis
of polyketides or nonribosomal peptides. Type II thioesterases
are responsible for the regeneration of misprimed PCP-domains
via hydrolytic cleavage of noncognate intermediates from the
40-ppant cofactor (Linne et al., 2004; Schwarzer et al., 2002;
Yeh et al., 2004). contrast to the well studied single TE domain
modular systems, LybB ends with an unusual tandem thioester-
ase architecture, which has only been reported for few NRPS
systems, namely arthrofactin, massetolide and syringopeptinChemistry & Biology 18,(de Bruijn et al., 2008; Roongsawang et al., 2003; Scholz-
Schroeder et al., 2003). In vivo characterization of arthrofactin
tandem TEs via site-directed mutagenesis and the generation
of deletion mutants gave first insights into the functionality of
both domains (Roongsawang et al., 2007). It was shown that
the Ser/Ala mutant of ArfC TE1 gave rise to arthrofactin nonpro-
ducing mutants. Deletion of ArfC TE2 or inactivation of the
domain led to a drastically decreased arthrofactin production
(5%), confirming ArfC TE2 to be directly involved in the efficient
production of the natural product.
Phylogenetic analysis of LybB TE1 and LybB TE2, compared
to thioesterases from NRPS- or PKS-systems, revealed the
TEs to cluster with several other tandem TEs (Figure S2). LybB
TE1 clusters with the TE1 domains found in the arthrofactin
(ArfC TE1), massetolide (MassC TE1), and syringopeptin (SypC
TE1) biosynthetic systems, which is also in full agreement with
the phylogenetic analyses conducted earlier (Roongsawang
et al., 2007). It was speculated that this subclass of TEs repre-
sents a novel cyclase family as all products of this group contain
a macrolactone moiety. LybB TE2, MassC TE2, ArfC TE2, and
SypC TE2 also constitute a discrete subclass of thioesterases.
In earlier studies, it was suggested that these TE2-domains do
not resemble variants of external TEIIs as they form a separate
branch within the phylogenetic tree.
Taken together, the results derived from sequential analysis
suggest both TEs to exhibit either cyclase or hydrolase activity.
To investigate the role of both thioesterase domains in the
process of lysobactin cyclization and product release, LybB
PCP-TE1-TE2, LybB PCP-TE1, LybB TE1, and LybB TE2 were
subcloned into the expression vector pET28a and heterolo-
gously produced in E. coli BL21 (DE3). Purification via Ni-NTA
agarose affinity chromatography (Figure S3) afforded 7.4 (PCP-
TE1-TE2/PCP-TE1), 3.0 (PCP-TE1), 1.6 (TE1), and 6.4 (TE2)
mg/L media recombinant protein. Interestingly, heterologous
production of LybB PCP-TE1-TE2 gave rise to proteolytic degra-
dation of the full length peptide, resulting in the simultaneous
purification of LybB PCP-TE1-TE2 and LybB PCP-TE1 (Fig-
ure S3D). The identity of the individual proteins was confirmed
via peptide mass fingerprinting. Peptide fragments obtained
from tryptic digestion were identified via HRMS-analysis and
are shown in Figure S3D and demonstrate the release of the
entire TE2 domain. To investigate if the cleavage of the full length
peptide is an autocatalytic event, the mixture of PCP-TE1-TE2
and PCP-TE1 was incubated for 2 days at various pH-values
(see Supplemental Experimental Procedures). SDS-PAGE anal-
ysis of the reactions did not reveal an increased formation of
PCP-TE1. LybB PCP-TE1-TE2 was also purified in the presence
of protease inhibitors to investigate the influence of protease
inhibition on protein cleavage. Addition of inhibitors (EDTA,
AEBSF, leupeptin, bestatin, aprotinin, and E-64 for the inhibition
of serine proteases, cysteine proteases, and metalloproteases)
did not reduce the cleavage of LybB PCP-TE1-TE2 (Figure S3E
and Supplemental Experimental Procedures). These results
suggest an intracellular E. coli protease to be involved in the
posttranslational cleavage of the enzyme during the heterolo-
gous production of the protein in vivo. It can be suggested
that LybB PCP-TE1-TE2 is also cleaved in the native strain
Lysobacter sp. ATCC 53042 before lysobactin synthesis
although it can only be speculated which specific protease is655–664, May 27, 2011 ª2011 Elsevier Ltd All rights reserved 659
Figure 5. Cyclization of the Thiophenol-Activated Substrate Medi-
ated by LybB PCP-TE1-TE2, LybB PCP-TE1, and LybB TE1
The HPLC traces correspond to the incubation of the substrate (Su, 100 mM)
with the recombinant enzymes for 2 hr at 25C. The red HPLC trace corre-
sponds to the control lacking the enzyme. The formation of nonenzymatically
cyclized peptides Cy0 and Cy00 is observed in the absence of the thioesterase.
Enzymatic conversion of the substrate (Su, tR = 10.2 min) leads to the hydro-
lytically cleaved peptide Hy at tR = 5.2 min and the macrolactone Cy at
tR = 7.5 min. See also Figures S3–S7.
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domain could then function as an external type II TE to regen-
erate misprimed PCP-domains via hydrolytic cleavage of the
PCP-bound noncognate substrates. Sequential analysis of
LybB TE1 and TE2 based on TE-core motifs, secondary struc-
ture elements and multiple sequence alignments with tandem
TE-domains revealed a region between a6 (TE1) and b1 (TE2)
lacking secondary structure motifs (Supplemental Experimental
Procedures). The 13 residues located in this proline-rich region
are considered to constitute the linker between LybB TE1 and
TE2 and could contain a putative protease cleavage site,
although it can only be speculated if a specific protease is
involved in the cleavage process (Figure S4). The conserved
proline residue that was considered to be the N terminus of
ArfC TE2 is also located within this region (Roongsawang
et al., 2007). To investigate the function of the individual LybB
thioesterases, a biochemical characterization was carried out
in vitro. This biochemical characterization of the thioesterases
relied on the potential of dissected TE domains to mediate either
hydrolysis or macrocyclization of artificial peptidyl-substrates
(Sieber et al., 2004). TE-domains remain catalytically active units
when separated from the enzymatic template and can be
incubated with synthetic substrates for the evaluation of their
inherent biocombinatorial potential (Kopp and Marahiel, 2007b).
These substrates are synthesized via solid-phase peptide
synthesis (SPPS), substituting the entire enzymatic machinery
(Kopp and Marahiel, 2007b; Trauger et al., 2000). Recognition
and cyclization of the synthetic substrate requires theC-terminal
activation of the oligopeptide as a thioester, imitating the physi-
ological situation of the naturally occurring PCP-ppant-bound
substrate (Kohli et al., 2002). Investigation of the individual
LybB TE domains required the synthesis of a cognate linear lyso-
bactin undecapaptide with minor modifications of the peptidic
backbone. The synthetically demanding amino acids hyLeu4
and hyAsn10 were substituted with nonhydroxylated L-Leu and
L-Asn, but stereochemistry was conserved throughout the oligo-
peptide. C-terminal activation of the peptide was accomplished
via thioesterification with thiophenol (Figure S5).
In vitro analysis of the TE domain activities was carried out by
incubating the recombinant enzyme with the artificial substrate.
All reactions were monitored via liquid chromatography-mass
spectrometry (LC-MS). In the control reaction, lacking the
enzymes, slight hydrolysis (Figure 5, Hy, tR = 4.2min) and nonen-
zymatic cyclization (Cy, Cy0, and Cy00, tR = 7.5, 9.4, and 9.9 min)
were observed (Figure S6). Thesemacrocyclic products are sug-
gested be derived from the intramolecular attack of three
different nucleophiles (the primary amino group of D-Leu1 and
the secondary hydroxyl groups of hyPhe3 and aThr8) onto the
activated C terminus of the peptide.
Incubation of the substrate (Su, tR = 10.2 min) with recombi-
nant LybB PCP-TE1-TE2/PCP-TE1 resulted in the complete
conversion of the undecapeptidyl-thioester to the macrocyclic
product (Cy, tR = 8.28 min) and the hydrolyzed linear peptide
(Hy, tR = 5.27 min). Cy
0 and Cy00, as observed in the control reac-
tion were not detected (Figure 5). This suggests that Cy is the
expected enzymatically generated lysobactin derivative result-
ing from ester bond formation between hyPhe3 and Ser11. In
addition, MS2-analysis of the macrocyclic product Cy revealed
the formation of b-series fragment ions carrying a dehydro-660 Chemistry & Biology 18, 655–664, May 27, 2011 ª2011 Elsevierphenylalanine species. This formation of dehydro-phenylalanine
species resulting from a loss of one molecule of water is charac-
teristic for the fragmentation of lactones(Crotti et al., 2004). Addi-
tional fragment ions of the y- and the b-series strongly support
the macrocycle to be the expected lysobactin derivative (Fig-
ure S7). The determination of kinetic parameters for LybB
PCP-TE1-TE2-mediated macrocyclication revealed the enzyme
to follow Michaelis-Menten-kinetics with KM = 1.03 mM and
kcat = 11.1 s
1, leading to a catalytic efficiency of kcat/KM =
10.8 s1 3 mM1.
In addition, LybB PCP-TE1 was employed to investigate the
potential influence of the C-terminal TE2 domain on the macro-
cyclization reaction. Analysis of the assay revealed the additional
domain to have no influence on product formation or hydrolysis
(Figure 5). The kinetic parameters were also determined for
this reaction and are the following: KM = 0.86 mM and kcat =
15.8 s1, leading to a catalytic efficiency of kcat/KM =
18.4 s1 3 mM1. Comparison of the kinetic profiles of LybB
PCP-TE1-TE2 and LybB PCP-TE1 reveals only minimal differ-
ences in the affinity for the substrate or substrate turnover. In
comparison with recombinant thioesterases derived from
NRPS pathways, LybB PCP-TE1-TE2 and LybB PCP-TE1
display lower affinities toward the substrate and exhibit higher
turnover rates. DptD PCP-TE, involved in daptomycin biosyn-
thesis, displays a KM = 50.1 mM and a kcat = 0.003 s
1, whereas
A54145-PCP-TE, mediating macrolactonization of A54145-
type acidic lipopeptides, shows a KM = 80.2 mM and a kcat =
0.0036 s1 (Grunewald et al., 2004; Kopp et al., 2006). LybB
TE1 was investigated for its macrocyclization potential and it
was shown that the enzyme also catalyzes the predominant
formation of the macrolactone (Figure 5). The reactions cata-
lyzed by LybB PCP-TE1-TE2, LybB PCP-TE1, and LybB TE1
exhibited comparable cyclization/hydrolysis ratios of 5.7, 4.6,Ltd All rights reserved
Figure 6. Hydrolysis of the Thiophenol-Activated Substrate Medi-
ated by LybB TE2
(A) The HPLC traces correspond to the incubation of the substrate (100 mM)
with the recombinant enzymes for 2 hr at 25C. The red HPLC trace corre-
sponds to the control lacking the enzyme. The formation of nonenzymatically
cyclized peptides Cy0 and Cy00 is observed in the absence and presence of the
thioesterase. Enzymatic conversion of the substrate (Su) leads to the
predominant formation of the hydrolytically cleaved peptide Hy at tR = 4.2 min.
(B) Results of the deacylation studies for LybB TEs and the stand-alone holo-
PCP SrfA-A PCP1. Analysis of residual radioactivity confirms LybB TE2 to
efficiently deacylate 14C-acetyl labeled PCP with 10% relative radioactivity
remaining. In contrast, LybB PCP-TE1 and LybB TE1 gave rise to 83% and
78% remaining radiolabel. Nonenzymatic hydrolysis afforded 91% residual
radioactivity. The quantification of radioactivity was based on the immediate
measurement of 14C-acetyl holo-PCP after loading in vitro (PCP*). One-
hundred percent (100%) represent 100,000 dpm.
See also Figures S3–S7.
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PCP-TE1-TE2 does not lead to an increase in hydrolysis or influ-
ence the yields of the macrocyclization reaction. In all cases, the
formation of the nonenzymatically cyclized peptides Cy0 and Cy00
was completely suppressed. Based on these results, it is evident
that the first thioesterase of LybB is mediating the stereospecific
macrolactonization of the linear lysobactin precursor.
As the in vivo characterization of tandem TEs in the arthrofac-
tin synthetase ArfC confirmed both TE domains to be functional
and involved in arthrofactin biosynthesis (Roongsawang et al.,
2007), the role of the second thioesterase LybB TE2 was also
investigated in vitro. Incubation of the enzyme with the substrate
gave rise to substantial conversion of the thioester to the
corresponding hydrolysis product (Hy, tR = 4.2 min) (Figure 6).
In addition, the three cyclization products (Cy, Cy0 and Cy00)Chemistry & Biology 18,were detected with comparable ratios. LybB TE2 displayed
a cyclization/hydrolysis ratio of 0.04 and is therefore considered
to solely mediate hydrolytic cleavage of thioester-activated
peptidyl-substrates similar to external type II thioesterases. To
further corroborate the function of LybB TE2 as a TEII-like
protein, deacylation studies, employing LybB TEs and the
stand-alone SrfA-A holo-PCP1, were carried out (Kraas et al.,
2010). SrfA-A PCP1 was artificially misprimed in vitro utilizing
Sfp and 14C-acetyl-CoA. Hydrolytic cleavage of the acetyl-group
was achieved by incubation of holo-PCP1 with recombinant
LybB TEs and residual radioactivity was quantified after precip-
itation of the enzymes. Analysis of the deacylation reactions
demonstrated LybB TE2 to efficiently hydrolyze the PCP-bound
acetyl group, thereby confirming the assigned catalytic function
of LybB TE2 as a TEII-like enzyme (Figure 6B). In contrast,
incubation of 14C-acetyl labeled PCP with LybB PCP-TE1 or
LybB TE1 did not result in substantial formation of deacylated
PCP, excluding TE1 to be involved in the regeneration of mis-
primed PCPs.
The results of this study contradict the mechanism that was
postulated based on the results of the in vivo characterization
of ArfC TEs. Roongsawang et al. proposed the second thioester-
ase domain of ArfC to mediate the macrocyclization of the
linear peptide, as the deletion and inactivation of this domain
drastically reduced arthrofactin production by 95% (Roongsa-
wang et al., 2007). It was postulated that, in a first step, the
peptidyl-substrate is transferred from the adjacent PCP-domain
onto the catalytically active serine residue of ArfC TE1. Subse-
quently, the lipoundecapeptidyl chain is transferred onto the
active-site serine of ArfC TE2. Ultimately, the intramolecular
attack of side-chain hydroxyl group of Thr leads to the formation
and release of the macrolactone.
The results obtained in this study assign different functions to
the individual TE domains. The in vitro characterization of TE1
clearly confirms this domain to be solely responsible for the
formation of the macrolactone and the subsequent release of
the product. Macrocyclization yields were not influenced by
the presence of the additional C-terminal TE2 domain, confirm-
ing the formation of the macrolactone to be the preferred reac-
tion. In contrast, LybB TE2 exclusively mediated the hydrolysis
of the thioester-activated substrate and the misprimed PCP. It is
suggested that LybB TE2 acts as a TEII-like thioesterase that
could deacylate misprimed PCPs. This efficient deacylation of
misprimed PCPs and ACPs by TEIIs has been reported for the
bacitracin TEII, the surfactin TEII or the ScoT TEII in vitro
(Kotowska et al., 2009; Schwarzer et al., 2002; Yeh et al.,
2004). In addition, the proteolytic cleavage of the C-terminal
TE2 domain has been observed and it cannot be ruled out
that this posttranslational cleavage generates a lone-standing
TEII-like protein in vivo. The reduced production of arthrofactin,
observed during the in vivo characterization of ArfC TEs, could
result from a decreased assembly line functionality due to
misacylated PCPs, which cannot be regenerated by the TEII-
like ArfC TE2 (Roongsawang et al., 2007). The disruption of
TEII-encoding genes in NRPS- or PKS-gene clusters is
commonly leading to a drastically decreased formation of the
corresponding natural product, which can be complemented
by a heterologous TEII (Kotowska et al., 2002; Schneider and
Marahiel, 1998).655–664, May 27, 2011 ª2011 Elsevier Ltd All rights reserved 661
Figure 7. Proposed Biosynthetic Model for
the Macrocyclization Reaction during Lyso-
bactin Assembly
Before LybB TE1 catalyzed formation of the
macrolactone, the undecapeptidyl-substrate is
transferred from the adjacent PCP-domain onto
the catalytically active serine residue. A subse-
quent intramolecular nucleophilic attack of the
hyPhe3 b-hydroxyl group onto the acyl-O-TE1
oxoester intermediate affords lysobactin. Accord-
ing to this model LybB TE2 acts as a TEII-like
protein in cis (A) or as a lone-standing thioesterase
in trans (B) to deacylate misprimed PCPs.
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macrocyclization reaction, whereas LybB TE2 deacylates
misprimed PCPs and ensures a continuous production of lyso-
bactin in cis (Figure 7A) or as a lone-standing TEII in trans
(Figure 7B).SIGNIFICANCE
Lysobactin represents a promising new agent for the treat-
ment of infections caused by Gram-positive pathogens
including MRSA and VRE, as its MOA differs from that of
the last-line antibiotic vancomycin. In the study presented
herein the gene cluster responsible for lysobactin assembly
was identified via sequencing and annotation of the
Lysobacter sp. ATCC 53042 genome. The lyb gene cluster
encodes twomultimodular NRPS and several proteins puta-
tively involved in resistance and secretion of the natural
product. The enzymatic assembly line consists of the two
synthetases LybA and LybB, containing four and seven
modules, respectively. Sequential analysis of the multimod-
ular organization and the predicted adenylation-domain
specificities suggested lysobactin assembly to follow
a conventional linear logic. Biochemical analysis of
A-domain specificities in vitro confirmed the predicted
substrate preferences and proved the correlation between
the primary sequence of lysobactin and the linear organiza-
tion of the synthetases LybA and LybB. The termination
module of LybB featured an unusual tandem TE architec-
ture, observed in only few NRPS biosynthetic pathways. To
determine the role of the individual thioesterase domains,
both were characterized in vitro using a thiophenol-
activated linear lysobactin analog. It was shown that LybB
TE1 exclusively catalyzed the formation of a macrocyclic
structure, whereas LybB TE2 solely mediated hydrolytic
cleavage of the synthetic substrate. This work represents
the first example of the biochemical characterization of
a tandem TE termination module and enables the assign-
ment of discrete catalytic activities for the individual662 Chemistry & Biology 18, 655–664, May 27, 2011 ª2011 Elsevier Ltd All rights reservedTE-domains. Based on these results
a chemoenzymatic approach utilizing
LybB TE1 will enable a rapid access
to lysobactin derivatives. In addition,
the identification of the lysobactin
assembly line offers the opportunityfor the combinatorial biosynthesis of lysobactin analogs
with improved pharmacological properties.EXPERIMENTAL PROCEDURES
Cultivation of Lysobacter sp., Fermentation, and Isolation
of Lysobactin
Lysobacter sp. ATCC 53042 was purchased from LGC Standards GmbH and
initially plated on soy agar slants (BBL Trypticase soy broth BD211768 15 g,
Agar Roth 2266.2 7.5 g in 500 ml water). Fermentations were carried out as
described earlier (Bonner et al., 1988; O’Sullivan et al., 1988). After centrifuga-
tion of the culture at 7000 rpm for 30 min, the supernatant was separated
(pH-value was adjusted to 7.0) and extracted with butanol. The solvent was
removed after combination of the extracts using rotary evaporator to yield
a yellow solid. The residue was dissolved in methanol and the soluble portion
was analyzed via LC-MS (Agilent/HP 1100 series, column: Macherey-Nagel cc
125/2 Nucleodur 100-3 c18 ec) with the following gradient: solvent A: water
(0.1% trifluoroacetic acid), solvent B: acetonitrile (0.1% trifluoroacetic acid),
flow rate: 0.3 ml/min, gradient: 0 min, 10% B, 30 min, 60% B, 33 min, 95%
B, 35 min 95% B, 38 min, 10% B, 45 min, 10% B). Lysobactin showed a reten-
tion time tR of 19.5 min under the conditions applied (m/z = 1276.8 [M + H]
+
observed, m/z = 1276.7 [M + H]+ calculated; Figure S1). HRMS-analysis of
lysobactin was performed via high resolution mass spectrometry on an
LTQ-FT instrument (Thermo Fisher Scientific) connected to a microbore
Agilent 1100 HPLC system.
Synthesis of the Thioester-Activated Peptidyl Substrate
L-threo-3-phenylserine hydrate (HyPhe) was purchased from Bachem. The
primary amino group was protected with 9-fluorenylmethyloxycarbonyl
(Fmoc) following a standard protocol (Watts et al., 2004). The undecapeptide
D-Leu1-Leu2-hyPhe3-Leu4-Leu5-D-Arg6-Ile7-aThr8-Gly9-Asn10-Ser11 was syn-
thesized (Aapptec, Apex 396 peptide synthesizer) following the standard Fmoc
solid phase peptide synthesis protocol. Thioesterification with thiophenol and
the subsequent cleavage of side chain protecting groups were carried out
following a protocol described earlier (Sieber et al., 2004). Purification of the
thiophenol-activated peptide was carried out via preparative HPLC (Agilent/
HP 1100 series, column: Macherey-Nagel VP 250/21 Nucleodur 100-5 c18
ec) with the following gradient: solvent A: water (0.1% trifluoroacetic acid),
solvent B: acetonitrile (0.1% trifluoroacetic acid), flow rate: 10 ml/min,
gradient: 0 min, 30% B, 30 min, 70% B, 32 min, 95% B, 35 min 95% B,
37 min, 30% B, 45 min, 30% B. After removal of the solvent via lyophilization,
the peptidyl-SPh substrate was dissolved in dimethyl sulfoxide (DMSO) to
obtain a final concentration of 100 mM.
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The reaction mixture (final volume 50 ml) containing 25 mM HEPES, 50 mM
NaCl, 10-400 mM peptidyl-SPh, 2 ml DMSO, and 1 mM enzyme was incubated
at 25C for a certain period of time (2 hr for activity analysis, 30 s for determi-
nation of kinetic parameters). The reaction was quenched by adding 50 ml
MeOH to precipitate the enzyme. After centrifugation at 13,000 rpm for
10 min, the resulting supernatant was analyzed via LC-MS (Agilent/HP 1100
series, column: Macherey-Nagel cc125/2 Nucleodur 100-3 c18 ec, column
temperature: 45C) with the following gradient: solvent A: water (0.1%
trifluoroacetic acid), solvent B: acetonitrile (0.1% trifluoroacetic acid), flow
rate: 0.3 ml/min, gradient: 0 min, 30% B, 20 min, 50% B, 23 min, 95% B,
30 min 95% B, 33 min, 30% B, 40 min, 30% B. Experiments were performed
in triplicate for the determination of kinetic parameters.
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